Company Filing History:
2 out of 102 
1 out of 964 
1 out of 34 
Years Active: 2017-2021
Title: Haim Bitterman: Innovator in Extracellular Matrix Research
Introduction
Haim Bitterman is a notable inventor based in Haifa, Israel. He has made significant contributions to the field of biomedical research, particularly in the development of innovative peptides and antibodies.
Latest Patents
Haim Bitterman holds 2 patents related to extracellular matrix metalloproteinase inducer (EMMPRIN) peptides and binding antibodies. His inventions provide isolated peptides from the protein EMMPRIN (CD147/Basigin) and antibodies directed against antigenic determinants within these peptides. The pharmaceutical compositions comprising these peptides and antibodies are disclosed, along with methods for their production and use in vaccination, immunotherapy, and diagnosis of proliferative, hyperpermeability, inflammatory, and angiogenesis-related diseases and disorders.
Career Highlights
Throughout his career, Haim Bitterman has worked with various organizations, including Mor Research Applications Ltd. and Technion Research & Development Foundation Limited. His work has been instrumental in advancing the understanding and treatment of complex diseases.
Collaborations
Haim Bitterman has collaborated with notable colleagues such as Michal A Rahat and Nitza Lahat. Their joint efforts have contributed to the development of innovative solutions in the biomedical field.
Conclusion
Haim Bitterman's work in the field of extracellular matrix research has led to significant advancements in medical science. His patents and collaborations reflect his commitment to improving healthcare through innovation.